Greenhaven Road Capital's Q3 2024 investor letter highlighted its +15% return for the quarter and +12% year-to-date. The letter discusses top holdings like Lifecore Biomedical, Inc.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Greenhaven Road Capital's Q3 2024 investor letter highlighted its +15% return for the quarter and +12% year-to-date. The letter discusses top holdings like Lifecore Biomedical, Inc.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing